Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ).
Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced a cash dividend for the third quarter of 2025, declaring RMB 2.1 per 10 shares. The dividend, subject to shareholder approval on November 19, 2025, will be paid on January 19, 2026, with specific withholding tax rates applied to different categories of shareholders. This announcement reflects the company’s commitment to providing returns to its investors and may influence its market positioning by attracting more stakeholders.
The most recent analyst rating on (HK:1858) stock is a Hold with a HK$17.00 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. operates in the medical instruments industry, focusing on the development and manufacturing of medical devices. The company is known for its innovative medical products and services, catering to a diverse market with a focus on quality and technological advancement.
Average Trading Volume: 2,061,478
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.81B
For a thorough assessment of 1858 stock, go to TipRanks’ Stock Analysis page.